The preparation and comparative in vitro biological properties of derivatives formed in the reaction of nystatin with N-glucuronamides
Falkowski, L.; Troka, E.; Stefańska, B.
Acta Poloniae Pharmaceutica 37(6): 635-636
1980
ISSN/ISBN: 0001-6837 PMID: 7027742 Document Number: 158481
High antifungal activity against Saccharomyces cerevisiae was demonstrated by the compounds formed in the reaction of nystatin with methyl, N-[3-(N',N'-dimethylamino)-propyl]- and N-[2-(N',N'-dimethylamino)-propyl]-amides of glucuronic acid.
Document emailed within 1 workday
Related Documents
Pecorari, P.; Vampa, G.; Albasini, A.; Rinaldi, M.; Melegari, M.; Costi, M.P. 1988: Preparation and physicochemical properties of uracil derivatives with potential biological activity Il Farmaco; Edizione Scientifica 43(4): 311-318Maqsood, I.; Masood, M.I.; Bashir, S.; Nawaz, H.M.A.; Anjum, A.A.; Shahzadi, I.; Ahmad, M.; Imran Masood, I.M. 2015: Preparation and in vitro evaluation of Nystatin micro emulsion based gel Pakistan Journal of Pharmaceutical Sciences 28(5): 1587-1593
Brzezińska, E.; Stańczak, A.; Ochocki, Z. 2003: Structure and biological activity of some 4-amino-3-cinnolinecarboxylic acid derivatives. QSAR analysis of cinnoline derivatives with antibacterial properties Acta Poloniae Pharmaceutica 60(1): 15-20
Cavallini, D.; Ricci, G.; Federici, G. 1983: The ketamine derivatives of thialysine, lanthionine, cystathionine, cystine: preparation and properties Progress in Clinical and Biological Research 125: 355-363
Machoń, Z.; Jasztold-Howorko, R. 1981: Synthesis and biological properties of some 5-aminoorotic acid derivatives Polish Journal of Pharmacology and Pharmacy 33(5): 545-552
Kuczyński, L.; Mrozikiewicz, A.; Poreba, K. 1982: Synthesis and biological properties of imidazo-[4,5-b]-pyridine derivatives Polish Journal of Pharmacology and Pharmacy 34(4): 229-238
Marona, H.; Krupińska, J.; Cebo, B.; Chłoń, G. 1989: Synthesis and biological properties of various amino alcohol derivatives of xanthone Acta Poloniae Pharmaceutica 46(3): 227-231
Mikołajczyk, J.; Kotulowa, W.; Kazimierczak, J.; Sikora, A.; Rogowska, W.; Cieślak, J. 1980: Beta-lactamase inhibitors. I. Synthesis and biological properties of penicillanic acid derivatives Acta Poloniae Pharmaceutica 37(6): 637-641
Gregán, F.; Durinda, J.; Tumová, I.; Polásek, E.; Borovanský, A. 1987: Preparation, physicochemical properties and biological activity of 1-(dimethylaminomethyl-cyclohexyl)-2-alkoxycarbanilates Ceskoslovenska Farmacie 36(10): 448-456
Patacchini, R.; Quartara, L.; Rovero, P.; Goso, C.; Maggi, C.A. 1993: Role of C-terminal amidation on the biological activity of neurokinin A derivatives with agonist and antagonist properties Journal of Pharmacology and Experimental Therapeutics 264(1): 17-21
Kondrat'eva, N.A.; Dobrynin, I.V.; Merkulov, M.F. 1978: Biological properties of an asparaginase-glutaminase preparation from Pseudomonas fluorescens in cell cultures Antibiotiki 23(2): 122-125
Robberecht, P.; Deschodt-Lanckman, M.; Woussen-Colle, M.C.; De Neef, P.; Camus, J.C.; Christophe, J. 1980: Butyryl derivatives of cyclic GMP interfere with the biological and the immunological properties of the pancreozymin-gastrin family of peptides Molecular Pharmacology 17(2): 268-274
Auclair, C.; Schwaller, M.A.; René, B.; Banoun, H.; Saucier, J.M.; Larsen, A.K. 1988: Relationships between physicochemical and biological properties in a series of oxazolopyridocarbazole derivatives (OPCd); comparison with related anti-tumor agents Anti-Cancer Drug Design 3(2): 133-144
Gorbunova, M.L.; Lobanova, E.I.; Drozd, T.E.; Turliun, S.A.; Maganchuk, V.P. 1989: The effect of Aerococcus viridans--the basis of the new therapeutic-prophylactic preparation M-bacterin--on the biological properties of Staphylococcus aureus Mikrobiolohichnyi Zhurnal 51(5): 77-81
Noishiki, Y.; Hata, C.; Tu, R.; Shen, S.H.; Lin, D.; Sung, H.W.; Witzel, T.; Wang, E.; Thyagarajan, K.; Tomizawa, Y. 1993: Development and evaluation of a pliable biological valved conduit. Part I: Preparation, biochemical properties, and histological findings International Journal of Artificial Organs 16(4): 192-198
Yancey, K.B. 1988: Biological properties of human C5a: selected in vitro and in vivo studies Clinical and Experimental Immunology 71(2): 207-210
Jarosz, J. 1978: Polypeptide antibiotic 26a from Bacillus subtilis. III. Physicochemical and biological in vitro properties Acta Microbiologica Polonica 27(4): 359-374
Godal, A.; Nilsen, N.O.; Klaveness, J.; Branden, J.Erik.; Nesland, J.M.; Peng, Q. 2006: New derivatives of 5-aminolevulinic acid for photodynamic therapy: chemical synthesis and porphyrin production in in vitro and in vivo biological systems Journal of Environmental Pathology Toxicology and Oncology: Official Organ of the International Society for Environmental Toxicology and Cancer 25(1-2): 109-126
Ma, B.; Yan, W.; Chen, J.; Qi, P.; Li, J.; Huang, N. 2016: Preparation of Biological Functional Magnetic Nanoparticles and Study on the Effect of Guiding Endothelial Progenitor Cells In Vitro Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 33(1): 136-143
Stozek, T.; Krówczyński, L.; Bohdanowicz, T. 1983: Comparative studies on drug release from tablets in vitro and its biological availability. II. Biological availability of sodium salicylate from tablets of various formulations Acta Poloniae Pharmaceutica 40(1): 77-87